Multiple sclerosis market expected to reach $33.0bn across the 7MM by 2034
The MS therapeutics market has entered an exciting phase, with the anticipated launches of late-stage pipeline products showing promise in targeting MS disease progression
The MS therapeutics market has entered an exciting phase, with the anticipated launches of late-stage pipeline products showing promise in targeting MS disease progression